Detalhe da pesquisa
1.
Phase I Safety and Feasibility Pilot of Hepatic Artery Infusion Chemotherapy in a Rural Catchment Area Using The Codman Vascular Catheter with The Medtronic SynchroMed II Pump for Intrahepatic Cancers.
Ann Surg Oncol
; 31(2): 1252-1263, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38006531
2.
Estimating the distribution of ratio of paired event times in phase II oncology trials.
Stat Med
; 42(3): 388-406, 2023 02 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36575855
3.
Macrophage Repolarization as a Therapeutic Strategy for Osteosarcoma.
Int J Mol Sci
; 24(3)2023 Feb 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36769180
4.
SYNE1 Mutation Is Associated with Increased Tumor Mutation Burden and Immune Cell Infiltration in Ovarian Cancer.
Int J Mol Sci
; 24(18)2023 Sep 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-37762518
5.
Metabolic Dysregulation Explains the Diverse Impacts of Obesity in Males and Females with Gastrointestinal Cancers.
Int J Mol Sci
; 24(13)2023 Jun 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-37446025
6.
Local data commons: the sleeping beauty in the community of data commons.
BMC Bioinformatics
; 23(Suppl 12): 386, 2022 Sep 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-36151511
7.
MEScan: a powerful statistical framework for genome-scale mutual exclusivity analysis of cancer mutations.
Bioinformatics
; 37(9): 1189-1197, 2021 06 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33165532
8.
Correlation Between Trough Level of Abiraterone and Prostate-Specific Antigen (PSA) Response in Metastatic Hormone-Sensitive Prostate Cancer.
Med Sci Monit
; 28: e938091, 2022 Oct 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36229939
9.
ASO Visual Abstract: Phase I Safety and Feasibility Pilot of Hepatic Artery Infusion Chemotherapy in a Rural Catchment Area Using the Codman Vascular Catheter with the Medtronic Synchromed II Pump for Intrahepatic Cancers.
Ann Surg Oncol
; 31(2): 1292-1293, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38006533
10.
Assessment of adherence and relative dose intensity with oral chemotherapy in oncology clinical trials at an academic medical center.
J Oncol Pharm Pract
; 24(5): 348-353, 2018 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-28457192
11.
A phase 1/2 trial of ublituximab, a novel anti-CD20 monoclonal antibody, in patients with B-cell non-Hodgkin lymphoma or chronic lymphocytic leukaemia previously exposed to rituximab.
Br J Haematol
; 177(2): 243-253, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28220479
12.
A phase I study of tivantinib in combination with temsirolimus in patients with advanced solid tumors.
Invest New Drugs
; 35(3): 290-297, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28004284
13.
A phase I study of perifosine with temsirolimus for recurrent pediatric solid tumors.
Pediatr Blood Cancer
; 64(7)2017 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-28035748
14.
A phase I study of selumetinib (AZD6244/ARRY-142866), a MEK1/2 inhibitor, in combination with cetuximab in refractory solid tumors and KRAS mutant colorectal cancer.
Invest New Drugs
; 34(2): 168-75, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26666244
15.
Three-arm, randomized, phase 2 study of carboplatin and paclitaxel in combination with cetuximab, cixutumumab, or both for advanced non-small cell lung cancer (NSCLC) patients who will not receive bevacizumab-based therapy: An Eastern Cooperative Oncology Group (ECOG) study (E4508).
Cancer
; 121(13): 2253-61, 2015 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25740387
16.
Soy food frequency questionnaire does not correlate with baseline isoflavone levels in patients with bladder cancer.
J Oncol Pharm Pract
; 21(2): 128-31, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24642450
17.
A Phase I study of intermittently dosed vorinostat in combination with bortezomib in patients with advanced solid tumors.
Invest New Drugs
; 32(2): 323-9, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24114123
18.
A phase I study of AT-101 with cisplatin and etoposide in patients with advanced solid tumors with an expanded cohort in extensive-stage small cell lung cancer.
Invest New Drugs
; 32(2): 295-302, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23860642
19.
Vorinostat and bortezomib as third-line therapy in patients with advanced non-small cell lung cancer: a Wisconsin Oncology Network Phase II study.
Invest New Drugs
; 32(1): 195-9, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23728919
20.
Non-melanoma skin cancer event rates in a formalized clinical trial setting: considerations for clinical trial design.
Eur J Cancer Prev
; 33(1): 69-72, 2024 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37401516